Skip to main content
Till KTH:s startsida

CB2021 Clinical applications of biotechnology 6.0 credits

Administer About course

The course addresses clinical applications of biotechnology to screen, diagnose, and select treatments. Applications are exemplified within two major diseases: breast cancer and cardiovascular diseases. Examples of how targeted treatments have been developed with the help of biotechnology are included.

Information per course offering

Course offerings are missing for current or upcoming semesters.

Course syllabus as PDF

Please note: all information from the Course syllabus is available on this page in an accessible format.

Course syllabus CB2021 (Autumn 2024–)
Headings with content from the Course syllabus CB2021 (Autumn 2024–) are denoted with an asterisk ( )

Content and learning outcomes

Course contents

The course in Clinical Applications of Biotechnology provides an orientation on biotechnological methods and measurements used in healthcare. The course provides both theoretical background and practical application of analytical methods. The course includes basic knowledge of molecular disease mechanisms, biomarkers, molecular biology tools and methods. New developments with the potential to be integrated in a clinical context are highlighted. The course includes ethics and sustainability.

Intended learning outcomes

Knowledge and understanding

After passing the course the student must be able to:

  • Describe basic concepts regarding the main parts of the course.
  • In text, explain basic principles for biotechnological methods and measurements of biological samples.
  • Give examples of clinical applications of biotechnology.

Skills and abilities

After passing the course the student must be able to:

  • Relate biotechnological applications with underlying molecular disease mechanisms.
  • Be able to apply diagnostic measurements and report results in writing and orally.

Values and approaches 

After passing the course the student must be able to:

  • Suggest biotechnological applications for clinical use and explain their benefits and disadvantages.
  • Reflect on the clinical use of biotechnology from an ethical, economic, ecological, and social perspective.

Literature and preparations

Specific prerequisites

Completed degree project 15 credits in technology or natural sciences, 20 credits courses in biotechnology, 10 credits courses in mathematics, and 20 credits courses in chemistry. English B/6.

Literature

You can find information about course literature either in the course memo for the course offering or in the course room in Canvas.

Examination and completion

If the course is discontinued, students may request to be examined during the following two academic years.

Grading scale

A, B, C, D, E, FX, F

Examination

  • LAB1 - Laboratory work,, 1.5 credits, grading scale: P, F
  • TEN1 - Written exam, 4.5 credits, grading scale: A, B, C, D, E, FX, F

Based on recommendation from KTH’s coordinator for disabilities, the examiner will decide how to adapt an examination for students with documented disability.

The examiner may apply another examination format when re-examining individual students.

Other requirements for final grade

There are elements with compulsory attendance.

Examiner

Profile picture Cecilia Williams

Ethical approach

  • All members of a group are responsible for the group's work.
  • In any assessment, every student shall honestly disclose any help received and sources used.
  • In an oral assessment, every student shall be able to present and answer questions about the entire assignment and solution.

Further information

Course room in Canvas

Registered students find further information about the implementation of the course in the course room in Canvas. A link to the course room can be found under the tab Studies in the Personal menu at the start of the course.

Offered by

CBH/Protein Science

Main field of study

Biotechnology, Molecular Life Science

Education cycle

Second cycle